Target intelligence / Profile preview

Immune system – indirect modulation via secreted cytokines and exosomes

Molecular classification
Other
01

Overview

Immune system – indirect modulation via secreted cytokines and exosomes refers to a biological process where cells communicate with and regulate the immune system through paracrine signaling rather than direct cell-to-cell contact. This mechanism involves the secretion of cytokines—small signaling proteins like interleukins and interferons—and exosomes, which are nanometer-sized extracellular vesicles containing proteins, lipids, and RNA (Wiklander et al., 2019, Nature Communications). These factors can travel through the extracellular space or systemic circulation to bind to receptors on distant immune cells, such as T cells and macrophages, thereby altering their activation state or function (Galipeau & Sensébé, 2018, Nature). In therapeutic contexts, this mechanism is frequently associated with mesenchymal stem cells (MSCs) and exosome-based therapies aimed at treating inflammatory and autoimmune disorders. Conversely, in oncology, tumors often exploit this pathway to secrete immunosuppressive factors that help them evade immune detection (Whiteside, 2016, Essays in Biochemistry). Because this term encompasses a vast array of distinct signaling molecules and pathways, it is considered a therapeutic mechanism or a mode of action rather than a single, discrete molecular target.

Other names
Paracrine immunomodulationExosome-mediated immune signalingCytokine-mediated immune regulationIndirect immune modulation
02

Mechanism of action

Modulation of immune cell activity through the secretion of soluble cytokines and extracellular vesicles (exosomes) that carry bioactive cargo to recipient cells.

03

Biological functions

Immune responseSignal transductionCell-to-cell communicationInflammatory response
04

Disease associations

CancerInflammationAutoimmune diseaseInfectionGraft-versus-host disease
05

Safety considerations

Cytokine release syndrome (CRS)Systemic immunosuppressionPotential for tumor microenvironment promotionImmunogenicity of therapeutic vesicles
06

Interacting drugs

Mesenchymal stem cell therapies

4 more in the full profile.

07

Biomarkers

Circulating cytokine levels (e.g., IL-6, IL-10, TNF-alpha)Exosomal surface markers (CD63, CD81, CD9)Exosomal microRNA profiles

Beyond the preview

Go deeper on Immune system – indirect modulation via secreted cytokines and exosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immune system – indirect modulation via secreted cytokines and exosomes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call